- Investing Ideas
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
71
71 companies
Zevra Therapeutics
Market Cap: US$595.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$10.07
7D
2.7%
1Y
25.9%
Madrigal Pharmaceuticals
Market Cap: US$11.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$513.72
7D
-1.2%
1Y
67.7%
Travere Therapeutics
Market Cap: US$4.1b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$44.12
7D
8.1%
1Y
106.1%
Bora Pharmaceuticals
Market Cap: NT$51.8b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$407.50
7D
0.4%
1Y
-29.9%
Camurus
Market Cap: SEK 31.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 531.00
7D
-1.2%
1Y
-19.5%
Syndax Pharmaceuticals
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$19.11
7D
-9.0%
1Y
40.8%
Starpharma Holdings
Market Cap: AU$299.0m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.74
7D
-1.3%
1Y
687.2%
Insmed
Market Cap: US$28.8b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$133.26
7D
-2.0%
1Y
83.6%
Bonesupport Holding
Market Cap: SEK 14.5b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 220.60
7D
-2.6%
1Y
-30.2%
HansBiomed
Market Cap: ₩419.3b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩29,850.00
7D
-10.0%
1Y
306.1%
Rhythm Pharmaceuticals
Market Cap: US$5.6b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.
RYTM
US$81.81
7D
-4.0%
1Y
27.0%
AnaptysBio
Market Cap: US$1.9b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$66.76
7D
0.3%
1Y
222.0%
Ardelyx
Market Cap: US$1.7b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.88
7D
14.9%
1Y
84.2%
Keymed Biosciences
Market Cap: HK$22.3b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$73.95
7D
-2.2%
1Y
54.1%
Guard Therapeutics International
Market Cap: SEK 21.4m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.06
7D
2.9%
1Y
-92.4%
WuXi XDC Cayman
Market Cap: HK$74.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$59.15
7D
2.0%
1Y
52.6%
Pelthos Therapeutics
Market Cap: US$83.9m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$25.00
7D
0.9%
1Y
110.1%
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€96.00
7D
-0.9%
1Y
25.2%
Aldeyra Therapeutics
Market Cap: US$95.7m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.59
7D
0.6%
1Y
-41.1%
Capricor Therapeutics
Market Cap: US$1.8b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$30.91
7D
-11.9%
1Y
200.1%
ARS Pharmaceuticals
Market Cap: US$850.0m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$8.56
7D
7.7%
1Y
-40.0%
Clinuvel Pharmaceuticals
Market Cap: AU$462.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.25
7D
3.0%
1Y
-18.5%
Imexpharm
Market Cap: ₫7.8t
Operates as a pharmaceutical company in Vietnam.
IMP
₫49,900.00
7D
3.2%
1Y
14.7%
CG Oncology
Market Cap: US$5.8b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$66.27
7D
-0.8%
1Y
135.2%
Oxford Biomedica
Market Cap: UK£716.9m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£5.93
7D
-3.1%
1Y
101.0%
Arcutis Biotherapeutics
Market Cap: US$2.9b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$23.35
7D
-0.3%
1Y
51.5%
GNI Group
Market Cap: JP¥168.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥3,020.00
7D
-3.5%
1Y
25.1%
Verrica Pharmaceuticals
Market Cap: US$107.7m
A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
VRCA
US$6.27
7D
-8.1%
1Y
40.7%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.40
7D
-3.2%
1Y
-18.5%
Kuros Biosciences
Market Cap: CHF 794.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.28
7D
-8.6%
1Y
-25.7%
Devyser Diagnostics
Market Cap: SEK 1.6b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 94.00
7D
-2.0%
1Y
-11.0%
IDL Diagnostics
Market Cap: SEK 80.6m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.35
7D
-4.1%
1Y
-40.5%
Neurocrine Biosciences
Market Cap: US$13.3b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$131.78
7D
2.9%
1Y
20.1%
SIGA Technologies
Market Cap: US$329.6m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$4.60
7D
0.9%
1Y
-14.8%
Belite Bio
Market Cap: US$6.1b
A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.
BLTE
US$154.85
7D
-5.0%
1Y
147.8%
Senores Pharmaceuticals
Market Cap: ₹41.4b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹894.25
7D
-4.8%
1Y
76.9%